Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)

Saxena, S. ., Renuka, J. ., Jeankumar, V. ., Yogeeswari, P. ., & Sriram, D. . Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. Current Topics in Medicinal Chemistry, 14(17), 1990-2005. Retrieved from http://www.eurekaselect.com/124977/article (Original work published 2014)

Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)

Samala, G. ., Devi, B. ., Saxena, S. ., Gunda, S. ., Yogeeswari, P. ., & Sriram, D. . (2016). Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo 4,5 thieno 2,3-d pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry, 24(21), 5556-5564. https://doi.org/10.1016/j.bmc.2016.09.012 (Original work published 2016)

Jeankumar, V. ., Reshma, R. ., Janupally, R. ., Saxena, S. ., Sridevi, J. ., Medapi, B. ., … Sriram, D. . (2015). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry, 13(8), 2423-31. https://doi.org/10.1039/c4ob02049a (Original work published 2015)

Saxena, S. ., Samala, G. ., Sridevi, J. ., Devi, P. ., Yogeeswari, P. ., & Sriram, D. . (2015). Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors. European Journal of Medicinal Chemistry, 92, 401-14. https://doi.org/10.1016/j.ejmech.2014.12.046 (Original work published 2015)

Devi, P. ., Jogula, S. ., Reddy, A. ., Saxena, S. ., Sridevi, J. ., Sriram, D. ., & Yogeeswari, P. . (2015). Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities. Molecular Informatics, 34(2-3), 147-59. https://doi.org/10.1002/minf.201400120

Saxena, S. ., Samala, G. ., Renuka, J. ., Sridevi, J. ., Yogeeswari, P. ., & Sriram, D. . (2015). Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain. Bioorganic & Medicinal Chemistry, 23(7), 1402-12. https://doi.org/10.1016/j.bmc.2015.02.032 (Original work published 2015)

Medapi, B. ., Renuka, J. ., Saxena, S. ., Sridevi, J. ., Medishetti, R. ., Kulkarni, P. ., … Sriram, D. . (2015). Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors. Bioorganic & Medicinal Chemistry, 23(9), 2062-78. https://doi.org/10.1016/j.bmc.2015.03.004 (Original work published 2015)

Petersen, G. ., Saxena, S. ., Renuka, J. ., , Yogeeswari, P. ., Santos, D. ., … Sriram, D. . (2015). Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase. Journal of Molecular Graphics & Modelling, 60, 124-31. https://doi.org/10.1016/j.jmgm.2015.05.001